Clinical Trial

The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.

Recruiting
View on ClinicalTrials.gov →
Summary
This research project aims to collect images from patients with chronic glomerulonephritis. For each subject, the images obtained from renal biopsy will undergo evaluation by both the diagnostic model and the 'gold standard' diagnosis by pathologists. The researchers will test the subjects using the diagnostic model and compare the results with the known 'gold standard' diagnosis, in order to evaluate the AUC, specificity, and sensitivity of the diagnostic model.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-28.
Trial Details
NCT Number NCT07330362
Lead Sponsor Zhujiang Hospital
Conditions Chronic Glomerulonephritis, Chronic Kidney Disease
Enrollment 2,900 participants
Start Date 2024-07-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-27